ArticleContemporary clinical trials communications2021

Neoadjuvant docetaxel, oxaliplatin plus S-1 for treating clinical stage III squamous cell carcinoma of the esophagus: Study protocol of an open-label phase II trial.

Mitsuro Kanda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.